MaryKate Lesnevich, Bristol Myers Squibb, USA; Kelly Soady, Oxford Pharmagenesis, UK; Eileen Burkart-Hartman, Takeda Pharmaceuticals USA, Inc., USA; Doreen Valentine, International Society for Medical Publications Professionals, USA; Vidhi Vashisht, Krystelis Ltd.,...
Your team at a sponsoring pharmaceutical company recently published a clinical study in a reputable journal. Soon after, a healthcare professional shared a summary generated by an AI-powered medical tool that appears to overstate the study’s efficacy and...
Perspectives from the ISMPP Academy 2025 session titled “Connecting the Dots: Alignment and Synergies in Medical Communications” Introduction Publications, medical education, and scientific content teams often sit at the center of a dense stakeholder network that...
As artificial intelligence (AI) continues to advance, its integration into the field of medical research and publication is increasing. The ISMPP Publication Ethics & Standards Committee, in collaboration with the ISMPP AI Task Force, is interested in...
Peggy Robinet, PharmD, PhD, ISMPP CMPP™, Parexel, USA; Simon Foulcer, PhD, ISMPP CMPP™, AstraZeneca, UK; Kamely Hayes, Parexel, USA In the ever-evolving landscape of medical communications, podcasts have emerged as a useful tool for disseminating medical information....
